Galectin Therapeutics INC (GALT) — DEF 14A Filings
All DEF 14A filings from Galectin Therapeutics INC. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Galectin Therapeutics Goes Virtual for 2025 Annual Meeting
— Oct 22, 2025 Risk: low
Galectin Therapeutics Inc. is holding its 2025 Annual Meeting virtually on December 3, 2025, to elect eleven directors, approve executive compensation on a non- -
Galectin Therapeutics Files 2024 Proxy Statement
— Dec 3, 2024 Risk: low
Galectin Therapeutics Inc. filed a DEF 14A proxy statement on December 3, 2024, for its annual meeting scheduled for January 23, 2025. The company, formerly kno
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX